1、 FAN Y P, LIAO J Z, LU Y Q,et al.MiR-375 and doxorubicin co-delivered by liposomes for combination therapy of hepatocellular carcinoma[J].Mol Ther Nucleic Acids, 2017(7):181-189. FAN Y P, LIAO J Z, LU Y Q,et al.MiR-375 and doxorubicin co-delivered by liposomes for combination therapy of hepatocellular carcinoma[J].Mol Ther Nucleic Acids, 2017(7):181-189.
2、 WANG W, LIU W, HUANG da B, et al. Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma[J]. AmJ Cancer Res, 2016,6(8):1681-1694. WANG W, LIU W, HUANG da B, et al. Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma[J]. AmJ Cancer Res, 2016,6(8):1681-1694.
3、 JIANG J X, GAO S, PAN Y Z,et al.Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II[J]. Mol Med Rep, 2014,10(2):995-1002. JIANG J X, GAO S, PAN Y Z,et al.Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II[J]. Mol Med Rep, 2014,10(2):995-1002.
4、 CHEN J S, LIANG L L, XU H X,et al. MiR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells[J].Oncotarget, 2017, 8(42): 71418-71429. CHEN J S, LIANG L L, XU H X,et al. MiR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells[J].Oncotarget, 2017, 8(42): 71418-71429.
5、 BIE B, SUN J, LI J,et al. Baicalein, a natural anti-cancer compound, alters MicroRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells[J]. Cell Physiol Biochem, 2017,41(4):1519-1531. BIE B, SUN J, LI J,et al. Baicalein, a natural anti-cancer compound, alters MicroRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells[J]. Cell Physiol Biochem, 2017,41(4):1519-1531.
6、 JIN F, WANG Y, LI M,et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy[J]. Cell Death Dis,2017,8(1):e2540. JIN F, WANG Y, LI M,et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy[J]. Cell Death Dis,2017,8(1):e2540.
7、 MENG W, TAI Y, ZHAO H,et al. Downregulation of miR-33a-5p in hepatocellular carcinoma: a possible mechanism for chemotherapy resistance[J]. Med Sci Monit, 2017,14(23):1295-1304. MENG W, TAI Y, ZHAO H,et al. Downregulation of miR-33a-5p in hepatocellular carcinoma: a possible mechanism for chemotherapy resistance[J]. Med Sci Monit, 2017,14(23):1295-1304.
8、 ZHANG T, LIU W, ZENG X C,et al. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma[J].Biomed Pharmacother,2016(84):583-591. ZHANG T, LIU W, ZENG X C,et al. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma[J].Biomed Pharmacother,2016(84):583-591.
9、 ZENG Y B, LIANG X H, ZHANG G X,et al. MiRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box ol[J]. Cancer Cell Int, 2016, 16(1):63. ZENG Y B, LIANG X H, ZHANG G X,et al. MiRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box ol[J]. Cancer Cell Int, 2016, 16(1):63.
10、 BAI P S, XIA N, SUN H,et al. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma[J].J Cell Mol Med, 2017,21(11):3023-3043. BAI P S, XIA N, SUN H,et al. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma[J].J Cell Mol Med, 2017,21(11):3023-3043.
11、 CONNOLLY E C, van DOORSLAER K, ROGLER L E,et al. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB[J]. Mol Cancer Res, 2010,8(5): 691-700. CONNOLLY E C, van DOORSLAER K, ROGLER L E,et al. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB[J]. Mol Cancer Res, 2010,8(5): 691-700.
12、 FORNARI F, MILAZZO M, CHIECO P,et al. MiR-199a-3pregulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells[J]. Cancer Res, 2010, 70(12): 5184-5193. FORNARI F, MILAZZO M, CHIECO P,et al. MiR-199a-3pregulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells[J]. Cancer Res, 2010, 70(12): 5184-5193.
13、 WANG Z, SONG D, HUANG P.MicroRNA?340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma[J].Mol Med Rep,2017, 16(5):7649-7656. WANG Z, SONG D, HUANG P.MicroRNA?340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma[J].Mol Med Rep,2017, 16(5):7649-7656.
14、 LI G, ZHANG W, GONG L,et al. MicroRNA-125a-5p inhibits cell proliferation and induces apoptosis in hepatitis b virus-related hepatocellular carcinoma by downregulation of ErbB3[J]. Oncol Res, 2017(8). LI G, ZHANG W, GONG L,et al. MicroRNA-125a-5p inhibits cell proliferation and induces apoptosis in hepatitis b virus-related hepatocellular carcinoma by downregulation of ErbB3[J]. Oncol Res, 2017(8).
15、 HE Q, WANG F, HONDA T,et al.Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice[J].Tumour Biol, 2017,39(10):1-8. HE Q, WANG F, HONDA T,et al.Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice[J].Tumour Biol, 2017,39(10):1-8.
16、 CONNOLLY E, MELEGARI M, LANDGRAF P. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirusassociated hepatocellular carcinoma contributes to the malignant phenotype[J]. Am J Pathol,2008, 173(3): 856-864. CONNOLLY E, MELEGARI M, LANDGRAF P. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirusassociated hepatocellular carcinoma contributes to the malignant phenotype[J]. Am J Pathol,2008, 173(3): 856-864.
17、 LUPINI L, BASSI C, FERRACIN M,et al. MiR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs[J]. Front Genet, 2013(4): 64. LUPINI L, BASSI C, FERRACIN M,et al. MiR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs[J]. Front Genet, 2013(4): 64.
18、 MAHAJAN V S, DRAKE A, CHEN J. Virus-specific host mirnas: Antiviral defenses or promoters of persistent infection?[J]. Trends Immunol, 2009, 30(1): 1-7. MAHAJAN V S, DRAKE A, CHEN J. Virus-specific host mirnas: Antiviral defenses or promoters of persistent infection?[J]. Trends Immunol, 2009, 30(1): 1-7.
19、 XIE Q, CHEN X, LU F,et al. Aberrant expression of microrna 155 may accelerate cell proliferation by targeting sex-determining region y box 6 in hepatocellularcarcinoma[J]. Cancer, 2012, 118(9): 2431-2442. XIE Q, CHEN X, LU F,et al. Aberrant expression of microrna 155 may accelerate cell proliferation by targeting sex-determining region y box 6 in hepatocellularcarcinoma[J]. Cancer, 2012, 118(9): 2431-2442.
20、 JIN J, TANG S, XIA L,et al. Microrna-501 promotes hbv replication by targeting hbxip[J]. Biochem Biophys Res Commun, 2013,430(4): 1228-1233. JIN J, TANG S, XIA L,et al. Microrna-501 promotes hbv replication by targeting hbxip[J]. Biochem Biophys Res Commun, 2013,430(4): 1228-1233.
21、 QIU L, FAN H, JIN W,et al. Mir-122-induced down-regulation of ho-1 negatively affects mir-122-mediated suppression of hbv[J]. Biochem Biophys Res Commun, 2010, 398(4): 771-777. QIU L, FAN H, JIN W,et al. Mir-122-induced down-regulation of ho-1 negatively affects mir-122-mediated suppression of hbv[J]. Biochem Biophys Res Commun, 2010, 398(4): 771-777.
22、 BANDOPADHYAY M, SARKAR N, DATTA S,et al. Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis[J].Infect Agent Cancer, 2016(11):40. BANDOPADHYAY M, SARKAR N, DATTA S,et al. Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis[J].Infect Agent Cancer, 2016(11):40.
23、 OTT J J, STEVENS G A, GROEGER J,et al. Global epidemiology of hepatitis b virus infection: New estimates of age-specific HBsaAG seroprevalence and endemicity[J]. Vaccine, 2012, 30(12):2212-2219. OTT J J, STEVENS G A, GROEGER J,et al. Global epidemiology of hepatitis b virus infection: New estimates of age-specific HBsaAG seroprevalence and endemicity[J]. Vaccine, 2012, 30(12):2212-2219.
24、 HU W, WANG X, DING X,et al. Microrna-141 represses hbv replication by targeting ppara[J]. PloS one, 2012, 7(3): e34165. HU W, WANG X, DING X,et al. Microrna-141 represses hbv replication by targeting ppara[J]. PloS one, 2012, 7(3): e34165.
25、 ZHOU S J, DENG Y L, LIANG H F,et al.Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma[J]. Cell Death Differ, 2017,24(9): 1577-1587. ZHOU S J, DENG Y L, LIANG H F,et al.Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma[J]. Cell Death Differ, 2017,24(9): 1577-1587.
26、 GAILHOUSTE L, OCHIYA T. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma[J]. Histol Histopathol, 2013, 28(4): 437-451. GAILHOUSTE L, OCHIYA T. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma[J]. Histol Histopathol, 2013, 28(4): 437-451.
27、 BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
28、 XIE K L, ZHANG Y G, LIU J,et al. MicroRNAs associated with HBV infection and HBV-related HCC[J]. Theranostics, 2014, 4(12):1176-1192. XIE K L, ZHANG Y G, LIU J,et al. MicroRNAs associated with HBV infection and HBV-related HCC[J]. Theranostics, 2014, 4(12):1176-1192.
